Loading…
Loading…
| RVMD | Revolution Medicines, Inc. | $183.29 | $39.0B |
| NUVL | Nuvalent, Inc. | $123.96 | $9.1B |
| PTGX | Protagonist Therapeutics, Inc. | $138.31 | $8.9B |
| ACLX | Arcellx, Inc. | $115.07 | $6.7B |
| KNSA | Kiniksa Pharmaceuticals International, plc | $63.55 | $4.8B |
| AKRO | Akero Therapeutics, Inc. | $54.65 | $4.5B |
| RLAY | Relay Therapeutics, Inc. | $19.30 | $3.4B |
| QURE | uniQure N.V. | $40.09 | $2.7B |
| SNDX | Syndax Pharmaceuticals, Inc. | $22.64 | $2.0B |
| STOK | Stoke Therapeutics, Inc. | $28.81 | $1.8B |
| VRDN | Viridian Therapeutics, Inc. | $19.18 | $1.7B |
| MGTX | MeiraGTx Holdings plc | $12.52 | $1.2B |
| CGEM | Cullinan Therapeutics, Inc. | $18.06 | $1.1B |
| VTYX | Ventyx Biosciences, Inc. | $14.00 | $1.0B |
| SLDB | Solid Biosciences Inc. | $8.46 | $659.1M |
| RCKT | Rocket Pharmaceuticals, Inc. | $3.40 | $371.3M |
| INZY | Inozyme Pharma, Inc. | $4.00 | $258.2M |
| RNA | Atrium Therapeutics, Inc. | $12.29 | $210.2M |
| BDTX | Black Diamond Therapeutics, Inc. | $1.87 | $107.2M |
| PLRX | Pliant Therapeutics, Inc. | $1.09 | $67.5M |